BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12831371)

  • 1. FTY720: A new kid on the block for transplant immunosuppression.
    Aki FT; Kahan BD
    Expert Opin Biol Ther; 2003 Jul; 3(4):665-81. PubMed ID: 12831371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTY720: from bench to bedside.
    Kahan BD
    Transplant Proc; 2004 Mar; 36(2 Suppl):531S-543S. PubMed ID: 15041402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on pharmacokinetic/pharmacodynamic studies with FTY720 and sirolimus.
    Kahan BD
    Ther Drug Monit; 2002 Feb; 24(1):47-52. PubMed ID: 11805722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines.
    Chen S; Bacon KB; Garcia G; Liao R; Pan ZK; Sullivan SK; Nakano H; Matsuzawa A; Brinkmann V; Feng L
    Transplant Proc; 2001; 33(7-8):3057-63. PubMed ID: 11750317
    [No Abstract]   [Full Text] [Related]  

  • 5. Preclinical evaluation of a new immunosuppressive agent, FTY720.
    Troncoso P; Kahan BD
    Clin Biochem; 1998 Jul; 31(5):369-73. PubMed ID: 9721436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
    Chiba K
    Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FTY720: early clinical experience.
    Dragun D; Fritsche L; Boehler T; Peters H; Budde K; Neumayer HH
    Transplant Proc; 2004 Mar; 36(2 Suppl):544S-548S. PubMed ID: 15041403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTY720 immunomodulation: optimism for improved transplant regimens.
    Ferguson R
    Transplant Proc; 2004 Mar; 36(2 Suppl):549S-553S. PubMed ID: 15041404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a novel immunosuppressant, FTY720, on allograft survival after renal transplant in rats.
    Ueda H; Takahara S; Azuma H; Kusaka M; Suzuki S; Katsuoka Y
    Eur Surg Res; 2000; 32(5):279-83. PubMed ID: 11111172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus in combination with FTY720--an analysis of renal and blood parameters.
    Gallo AP; Silva LB; Franco M; Burdmann EA; Bueno V
    Int Immunopharmacol; 2006 Dec; 6(13-14):1919-24. PubMed ID: 17219691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury.
    Dragun D; Böhler T; Nieminen-Kelhä M; Waiser J; Schneider W; Haller H; Luft FC; Budde K; Neumayer HH
    Kidney Int; 2004 Mar; 65(3):1076-83. PubMed ID: 14871428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New therapeutic approach for autoimmune diseases by the sphingosine 1-phosphate receptor modulator, fingolimod (FTY720)].
    Chiba K
    Yakugaku Zasshi; 2009 Jun; 129(6):655-65. PubMed ID: 19483408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine.
    Troncoso P; Stepkowski SM; Wang ME; Qu X; Chueh SC; Clark J; Kahan BD
    Transplantation; 1999 Jan; 67(1):145-51. PubMed ID: 9921811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTY720: a new immunosuppressive agent with novel mechanism(s) of action.
    Kahan BD
    Transplant Proc; 1998 Aug; 30(5):2210-3. PubMed ID: 9723444
    [No Abstract]   [Full Text] [Related]  

  • 15. FTY720 in combination with CsA inhibits islet xenograft rejection: a study in the pig-to-rat model.
    Zhang J; Song Z; Wijkström M; Bari S; Sundberg B; Nava S; Groth CG; Korsgren O; Wennberg L
    Transplant Proc; 2000 Aug; 32(5):1017. PubMed ID: 10936327
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate.
    Chiba K; Hoshino Y; Ohtsuki M; Kataoka H; Maeda Y; Matsuyuki H; Sugahara K; Kiuchi M; Hirose R; Adachi K
    Transplant Proc; 2005; 37(1):102-6. PubMed ID: 15808561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression with FTY720 and cyclosporine A inhibits rejection of adult porcine islet xenografts in rats.
    Maeda A; Goto M; Zhang J; Bennet W; Groth CG; Korsgren O; Wennberg L
    Transplantation; 2003 Apr; 75(8):1409-14. PubMed ID: 12717240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of graft rejection and graft-versus-host reaction by a novel immunosuppressant, FTY720, in rat small bowel transplantation.
    Mitsusada M; Suzuki S; Kobayashi E; Enosawa S; Kakefuda T; Miyata M
    Transpl Int; 1997; 10(5):343-9. PubMed ID: 9287398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTY 720.
    Drugs R D; 1999 Jan; 1(1):78-80. PubMed ID: 10565994
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
    Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD
    Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.